ArticleFood science & nutrition2025
D-Carvone Mitigating Renal Damage and Enhancing Antioxidant Defense in Lithium Induced Nephrotoxicity.
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lithium-induced nephrotoxicity presents a major health concern due to its detrimental impact on renal function, as is frequently observed in clinical and experimental settings. Despite various efforts to address this issue, effective treatment options remain limited. D-Carvone, a natural compound with antioxidants and anti-inflammatory properties, has demonstrated promise in reducing oxidative stress and inflammation. The present study aimed to explore the therapeutic impact of D-Carvone in alleviating lithium-induced nephrotoxicity, with a particular focus on oxidative stress indicators, apoptosis, inflammation, and histological changes in renal tissue. To this end, a total of 24 male rats were divided into four groups: Control, Lithium, Lithium + D-Carvone (20 mg/kg daily), and D-Carvone alone, with six animals per group. Lithium-induced nephrotoxicity was evaluated over 14 days. Oxidative stress was measured by evaluating malondialdehyde (MDA), glutathione (GSH) levels, and superoxide dismutase (SOD) activity. The expression of Caspase-3, Bcl-2, HO-1, TLR4, NRF2, and NF-κB-p65 was analyzed to assess apoptotic, inflammatory, and oxidative stress pathways. A histopathological examination of the kidney cortex and medulla was conducted. The results revealed that lithium administration caused significant histological damage, increased oxidative stress, and altered apoptotic and inflammatory protein expression. D-Carvone treatment reduced lipid peroxidation, restored apoptotic protein balance, alleviated inflammation, and protected renal tissue. These findings highlight the potential of D-Carvone as an adjuvant therapy for mitigating the nephrotoxic effects of lithium.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.